Literature DB >> 31975635

Tectonic keratoplasty using small incision lenticule extraction-extracted intrastromal lenticule for corneal lesions.

Om Prakash Pant1, Ji-Long Hao1, Dan-Dan Zhou2, Manju Pant3, Cheng-Wei Lu1.   

Abstract

Entities:  

Keywords:  Cornea transplantation; corneal lesions; corneal perforation; corneal thinning; lenticule; small incision refractive lenticule extraction; tectonic keratoplasty; visual acuity

Year:  2020        PMID: 31975635      PMCID: PMC7113716          DOI: 10.1177/0300060519897668

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


× No keyword cloud information.

Introduction

Corneal lesions, such as corneal thinning and perforation, are sight-threatening complications of corneal diseases.[1] Urgent surgical intervention is therefore necessary to preserve the anatomic integrity of the eyeball and prevent disastrous complications such as retinal detachment, secondary glaucoma, endophthalmitis, and panuveitis.[2] Thus far, corneal gluing, bandage contact lens, amniotic membrane transplantation, and conjunctival flap can be used as temporary treatments for corneal lesions.[3,4] However, the long-term outcomes of bandage contact lens, multilayered amniotic membrane transplantation, and conjunctival flaps are unsatisfactory. Furthermore, for most patients with corneal lesions, corneal transplantation is the sole treatment option currently available.[5,6] However, a shortage of donor corneas is an important limiting factor in corneal transplantation, especially in developing countries such as China, where the graft demand is very high.[7] Small incision refractive lenticule extraction (SMILE) is a femtosecond laser technique used for the correction of myopia and myopic astigmatism; this technique uses the VisuMax FS laser system (Carl Zeiss Meditec, Jena, Germany) to extract intrastromal corneal lenticule.[8] In this study, we used intrastromal lenticule extracted with the SMILE procedure as corneal patch graft in tectonic keratoplasty for the treatment of corneal thinning and perforation.

Methods

Patients

This study protocol was approved by the Institutional Ethics Committee of the First Hospital of Jilin University and was performed in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all patients prior to participation in this study. This non-comparative retrospective study included patients who were diagnosed with corneal lesions (corneal thinning or corneal perforation) secondary to ocular pathology (e.g., corneal ulcer, recurrent pterygium, blepharokeratoconjunctivitis, limbal dermoid, exposure keratitis, and/or pseudopterygium) and who underwent tectonic keratoplasty using SMILE-extracted lenticule in the Department of Ophthalmology of the First Hospital of Jilin University, Changchun, China from March 2017 to October 2018. Patients with very large corneal lesions, bilateral ocular defects requiring intervention, and/or prior cornea transplantation were excluded from the study. From the medical charts of eligible patients, data were recorded regarding age, sex, diagnosis, corneal status, corneal lesion location and size, preoperative and postoperative visual acuity (VA), lenticule layer used for transplantation, surgical procedure, and additional medical history. VA was recorded using the decimal system. The corneal lesion size and location were determined by slit-lamp examination or anterior segment optical coherence tomography (Visante OCT, Carl Zeiss Meditec). Corneal perforation was assessed by slit-lamp examination or by Seidel test with fluorescein staining. All lenticule donors who underwent the SMILE procedure had provided written informed consent for donation. All donors were healthy individuals and ranged in age from 16 to 35 years. The donor inclusion criteria were myopic spherical refractive error of −6 to −10 diopters; astigmatism <−0.5 diopters; negative serological findings for infectious disease; no malignancy, ocular disease, or ocular infection; and no systemic disease.

Surgical procedure

Under retrobulbar block, the initial surgical procedure was performed; debridement was performed in patients with corneal ulcer, while excision was performed in patients with dermoid or recurrent pterygium. The size of the corneal lesion was then measured using a caliper. SMILE lenticule, extracted using a VisuMax Femtosecond laser, was placed in the area with lesion. In patients who received single-layer lenticules, size 10-0 nylon cardinal sutures (synthetic, monofilament, and non-absorbable; Ethicon, San Lorenzo, Puerto Rico) were placed at 12 o’clock and 6 o’clock, immediately followed by cardinal sutures at 3 o’clock and 9 o’clock. Subsequently, the remaining sutures were placed. In patients who received double-layer lenticules, the single lenticule pieces were trimmed to the size of the lesion and then sutured using three interrupted 10-0 nylon sutures at 1 o’clock, 4 o’clock, and 9 o’clock. A second lenticule piece was placed over the sutured lenticule and both lenticules were sutured together with interrupted 10-0 nylon sutures.

Postoperative treatment and evaluation

Postoperatively, patients were prescribed topical 0.3% ofloxacin (Allergan, Irvine, CA, USA) four times per day for 2 months, as well as topical steroids (1% prednisolone, Allergan) four times per day for 1 month. After 1 month, steroid treatment was gradually tapered to twice per day, then maintained at that dosage for 6 months. There were no steroid-related complications. Artificial tear eye drops were also prescribed. Patients with blepharokeratoconjunctivitis were advised to scrub the eyelid with tea tree oil, maintain lid hygiene, and use warm compression daily. In addition, antibiotic eye ointment (0.3% ofloxacin eye ointment: Santen, Japan) was administered to all patients, twice daily for the first month. In patients with fungal keratitis, topical antifungal drugs (5% natamycin; Alcon, Fort Worth, TX, USA) were used. Patients were examined postoperatively on days 1, 2, 4, 7, 14, and 21; they were then examined once per month for 6 months. Slit-lamp microscopy was used to assess the healing of the cornea on first postoperative day. The following assessments were performed at each follow-up visit, beginning on postoperative day 7: best-corrected decimal VA, slit-lamp microscopy, and anterior segment optical coherence tomography. All complications were recorded. Surgical success was defined as recovery of corneal thinning or perforation and survival of the corneal grafts.

Statistical analysis

All statistical analyses were conducted using PASW Statistics for Windows, version 18.0 (SPSS Inc., Chicago, IL, USA). Quantitative data were expressed as mean ± standard deviation and qualitative data were expressed as number (percentage). Because there were fewer than 40 patients, the comparisons among patients were performed using Fisher’s exact test. P < 0.05 was considered statistically significant.

Results

We evaluated 18 patients with various corneal lesions who underwent tectonic keratoplasty using SMILE-extracted lenticule. After application of inclusion and exclusion criteria, all 18 patients were included in the analysis. Tables 1 and 2 describe the characteristics of the included patients. Notably, in two patients (11.1%), the surgical outcome was poor; re-implantation of the lenticule was performed in one patient with exposure keratitis and conjunctival flap surgery was performed in a patient with corneal ulcer to seal the perforation and preserve the anatomical structure of eyeball.
Table 1.

Summary of patient demographic and clinical characteristics.

Characteristic
Sex, M/F (n [%])10/8 (55.6%/44.4%)
Age, years (mean ± standard deviation [range])46.2±25.2 (7–82)
Prior medical history, yes/no (n [%])6/12 (33.3%/66.7%)
Occupation
 Farmer (n [%])7 (38.9%)
 Student (n [%])6 (33.3%)
 Other (n [%])5 (27.8%)
Affected eye, left/right (n [%])7/11 (38.9%/61.1%)
Predisposing pathology
 Corneal ulcer (n [%])11 (61.1%)
 BKC (n [%])2 (11.1%)
 Limbal dermoid (n [%])2 (11.1%)
 Recurrent pterygium (n [%])1 (5.6%)
 Exposure keratitis (n [%])1 (5.6%)
 Pseudopterygium (n [%])1 (5.6%)
Corneal status
 Thin (n [%])13 (72.2%)
 Perforated (n [%])5 (27.8%)
Lesion location
 Infratemporal (n [%])8 (44.4%)
 Central (n [%])6 (33.3%)
 Nasal (n [%])2 (11.1%)
 Supratemporal (n [%])1 (5.6%)
 Infranasal (n [%])1 (5.6%)
Lesion size
 <3 mm × 3 mm (n [%])4 (22.2%)
 ≥3 mm × 3 mm (n [%])14 (77.8%)
Preoperative visual acuity, decimal(mean ± standard deviation [range])0.2555±0.3326(light perception–1.00)
Postoperative visual acuity, decimal(mean ± standard deviation [range])0.3303±0.3487(light perception–1.00)
Graft lenticule layer
 Single (n [%])11 (61.1%)
 Double (n [%])7 (38.9%)
Postoperative visual acuity outcome, unchanged/improved (n [%])11/7 (61.1%/38.9%)

Abbreviations: M, male; F, female; BKC, blepharokeratoconjunctivitis.

Table 2.

Detailed patient demographic and clinical characteristics.

Age/eye/sexDiagnosisSymptomsCorneal statusLesion locationLesion size (mm)Preoperative VA (decimal)Postoperative VA (decimal)Lenticule layerFollow-up period (months)Medical historyOccupation
66/L/MRecurrent pterygiumFB sensationThinningIF3 × 30.80.8Single16NoOther
82/L/FCUIris prolapsePerforationIF4 × 3HM0.1Single12NoOther
77/L/MCURednessThinningCentral5 × 5LPLPSingle14DMFarmer
19/R/FLimbal dermoidFB sensationThinningIF2 × 30.250.5Single14NoStudent
41/R/MExposure keratitisFB sensationThinningCentral5 × 40.010.01Single12Brain tumorOther
41/R/MCURednessThinningCentral5 × 4HMHMSingle18NoFarmer
50/L/FCUIris prolapsePerforationIF5 × 4HM0.1Single12HTN, RAFarmer
18/R/MBKCIris prolapsePerforationIF2 × 20.20.3Single12NoStudent
22/R/MMooren CURednessThinningST3 × 40.50.5Double14NoStudent
65/R/MCURednessThinningIF4 × 40.40.5Double13NoFarmer
69/L/FCURednessThinningCentral3 × 40.010.01Double13NoFarmer
66/R/FCURednessThinningIF5 × 50.010.01Double12RAFarmer
7/R/FPseudopterygiumFB sensationThinningIN4 × 40.50.8Double11KeratoconusStudent
61/R/MCURednessThinningCentral3 × 4LPLPSingle11NoFarmer
76/L/MCUIris prolapsePerforationNasal3 × 20.80.8Double10DM, HTNOther
14/R/MLimbal dermoidFB sensationThinningIN3 × 311Single10NoStudent
44/L/FCURednessThinningCentral4 × 50.010.01Single9NoOther
14/R/FBKCIris prolapsePerforationIF2 × 20.10.5Double19NoStudent

Abbreviations: M, male; F, female; L, left; R, right; IF, infratemporal; IN, infranasal; DM, diabetes mellitus; HTN, hypertension; RA, rheumatoid arthritis; CU, corneal ulcer; BKC, blepharokeratoconjunctivitis; HM, hand motion; LP, light perception; VA, visual acuity.

Summary of patient demographic and clinical characteristics. Abbreviations: M, male; F, female; BKC, blepharokeratoconjunctivitis. Detailed patient demographic and clinical characteristics. Abbreviations: M, male; F, female; L, left; R, right; IF, infratemporal; IN, infranasal; DM, diabetes mellitus; HTN, hypertension; RA, rheumatoid arthritis; CU, corneal ulcer; BKC, blepharokeratoconjunctivitis; HM, hand motion; LP, light perception; VA, visual acuity. Stratification on the basis of postoperative VA outcome revealed that there were no significant differences in age, sex, affected eye, predisposing pathology, lesion size, lenticule layer, follow-up period, or occupation. However, corneal status and lesion location significantly differed on the basis of postoperative VA outcome (P < 0.05). VA improvement was greater in patients with corneal perforation than in patients with corneal thinning. In addition, VA was most improved in patients with infratemporal lesions (Table 3).
Table 3.

Comparisons between patients based on postoperative visual acuity outcome.

VariableImproved VAUnchanged VA P
Sex
 Male280.145
 Female53
Age
 <60 years550.367
 ≥60 years26
Occupation
 Farmer25
 Student420.280
 Other14
Affected eye
 Left250.637
 Right56
Predisposing pathology
 Corneal ulcer380.332
 Other43
Corneal status
 Thinning3100.047
 Perforation41
Lesion location
 Infratemporal620.010
 Central06
 Other13
Lesion size (mm)
 <3 mm × 3 mm310.245
 ≥3 mm × 3 mm410
Lenticule layer
 Single471.000
 Double34
Follow-up period (months)
 ≤12461.000
 >1235

Abbreviation: VA, visual acuity.

Comparisons between patients based on postoperative visual acuity outcome. Abbreviation: VA, visual acuity. Stratification on the basis of corneal status revealed no differences in age, sex, affected eye, predisposing pathology, lesion location, lenticule layer, or follow-up period. However, there was a significant difference in lesion size on the basis of corneal status (P < 0.05). Corneal perforation was more common in patients with lesion size < 3 mm × 3 mm, whereas corneal thinning was more common in patients with lesion size ≥ 3 mm × 3 mm (Table 4).
Table 4.

Comparisons between patients based on corneal status.

VariableCorneal thinningCorneal perforation P
Sex
 Male820.608
 Female53
Age
 < 60 years731.000
 ≥ 60 years62
Affected eye
 Left430.326
 Right92
Predisposing pathology
 Corneal ulcer831.000
 Other52
Lesion location
 Infratemporal440.119
 Central60
 Other31
Lesion size (mm)
 <3 mm × 3 mm130.044
 ≥3 mm × 3 mm122
Lenticule layer
 Single831.000
 Double52
Follow-up period (months)
 ≤12640.314
 >1271
Comparisons between patients based on corneal status.

Discussion

Corneal thinning involves a reduction in the total thickness of the cornea, which may lead to perforation in severe cases.[9] Corneal perforation is an ophthalmic emergency that requires immediate intervention. In addition to the risk of permanent loss of vision, these lesions may reduce patients’ quality of life. The etiology of corneal perforation can be traumatic (e.g., penetrating trauma or burns) or non-traumatic (e.g., corneal infections [bacterial, viral, or fungal] or autoimmune keratitis).[1,10-12] If left untreated, corneal thinning can result in perforation, which involves various complications including severe loss of anterior segment anatomical integrity, as well as endophthalmitis, panuveitis, secondary glaucoma, and irreversible vision loss.[2] Hence, timely diagnosis and proper intervention is needed to prevent these complications. Numerous treatment options are available based on the size and location of the lesion.[4,13] However, for patients with unresponsive lesions and for patients with large perforations, keratoplasty is the only treatment option.[14] Although keratoplasty is an effective and safe surgical approach for the treatment of corneal lesions, it has a few limitations in developing nations including lack of access to an eye bank, high cost of donor cornea, severe shortage of corneal tissue, lack of trained ophthalmologist/eye care providers, and patient resistance to transplantation.[15,16] Of these limitations, the severe shortage of corneal tissue is the primary barrier in developing nations. In this study, we performed tectonic keratoplasty using SMILE-extracted lenticule in patients with corneal lesions. The aim of tectonic keratoplasty using SMILE-extracted lenticule is to restore eyeball integrity and facilitate visual rehabilitation. The procedure was successful for 16 of 18 patients in the initial attempt; of the remaining two patients, one underwent re-implantation of the lenticule and one underwent conjunctival grafting. Furthermore, we observed that the eyeball integrity was restored in all patients who underwent the tectonic keratoplasty procedure. No adverse effects were observed during the follow-up period, such as infection, graft melting, or graft rejection. We concluded that this procedure is effective for preservation of the anatomical eyeball structure. Our findings are consistent with those of Wu et al.,[17] who reported the use of SMILE lenticule as a patch graft in six patients with corneal ulcer perforation; notably, they suggested that the application of SMILE-extracted lenticule may be a reliable and efficient surgical alternative for closure of corneal perforation, as well as for maintenance of the anatomical eyeball structure. Based on our findings, we recommend single-layer lenticule for patients with superficial lesions, as well as those with uncomplicated lesions; we recommend double-layer lenticule for patients with deep, large, and complicated corneal lesions. In this study, we observed that mean best-corrected VA was improved after the procedure, which indicates that tectonic keratoplasty using SMILE-extracted lenticule is effective for visual recovery. Similarly, Jiang et al.[18] observed improved VA in 22 eyes with corneal ulcer and perforation that underwent tectonic keratoplasty using SMILE-extracted lenticule; they also suggested that this approach could be used for treatment of inflammation. In our study, the extracted lenticule was sutured using interrupted 10-0 nylon sutures; this approach was advantageous in that it reduced the risks of corneal epithelial erosion, recurrent graft loss, granulomatous keratitis, and Tenon’s cyst, all of which are common complications associated with the use of fibrin glue for grafting.[19] The major limitations of this study were its small sample size and short follow-up period. Hence, a larger prospective study with long-term follow-up is needed to confirm our findings. In conclusion, tectonic keratoplasty using SMILE-extracted lenticule is a comparatively safe, effective, and reliable alterative approach for the treatment of corneal lesions. In addition to maintaining the anatomical eyeball integrity and facilitating visual rehabilitation, it is functionally and cosmetically effective. Furthermore, this technique can be used in emergency conditions, and can resolve the problems of donor shortage and high cost of donor cornea in developing nations.
  19 in total

1.  Nontraumatic corneal perforation.

Authors:  M Lekskul; H U Fracht; E J Cohen; C J Rapuano; P R Laibson
Journal:  Cornea       Date:  2000-05       Impact factor: 2.651

Review 2.  Management of corneal perforation.

Authors:  Vishal Jhanji; Alvin L Young; Jod S Mehta; Namrata Sharma; Tushar Agarwal; Rasik B Vajpayee
Journal:  Surv Ophthalmol       Date:  2011 Nov-Dec       Impact factor: 6.048

3.  Effect of corneal graft diameter on therapeutic penetrating keratoplasty for fungal keratitis.

Authors:  Cui Li; Gui-Qiu Zhao; Cheng-Ye Che; Jing Lin; Na Li; Wen-Yan Jia; Qiu-Qiu Zhang; Nan Jiang; Li-Ting Hu
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

4.  Multilayered amniotic membrane transplantation for severe ulceration of the cornea and sclera.

Authors:  K Hanada; J Shimazaki; S Shimmura; K Tsubota
Journal:  Am J Ophthalmol       Date:  2001-03       Impact factor: 5.258

5.  Small incision corneal refractive surgery using the small incision lenticule extraction (SMILE) procedure for the correction of myopia and myopic astigmatism: results of a 6 month prospective study.

Authors:  Walter Sekundo; Kathleen S Kunert; Marcus Blum
Journal:  Br J Ophthalmol       Date:  2010-07-03       Impact factor: 4.638

6.  Therapeutic keratoplasty for advanced suppurative keratitis.

Authors:  Seng-Ei Ti; J Angus Scott; Prathiba Janardhanan; Donald T H Tan
Journal:  Am J Ophthalmol       Date:  2007-02-28       Impact factor: 5.258

7.  Primary diseases of corneal perforation in Shandong Province, China: a 10-year retrospective study.

Authors:  Lixin Xie; Hualei Zhai; Xiaoguang Dong; Weiyun Shi
Journal:  Am J Ophthalmol       Date:  2008-02-15       Impact factor: 5.258

8.  Management of a small paracentral corneal perforation using iatrogenic iris incarceration and tissue adhesive.

Authors:  Akira Kobayashi; Hideaki Yokogawa; Kazuhisa Sugiyama
Journal:  Case Rep Ophthalmol       Date:  2012-07-10

9.  Limitations of Keratoplasty in China: A Survey Analysis.

Authors:  Jiaxu Hong; Weiyun Shi; Zuguo Liu; Roberto Pineda; Xinhan Cui; Xinghuai Sun; Jianjiang Xu
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

10.  Modified conjunctival flap as a primary procedure for nontraumatic acute corneal perforation.

Authors:  Yi-Chen Sun; Jason P Kam; Tueng T Shen
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2018 Jan-Mar
View more
  1 in total

1.  Therapeutic and tectonic keratoplasty with simple cryopreserved remnants of donor corneas: an 11 year retrospective case series.

Authors:  Jae-Gon Kim; Jong Hwa Jun
Journal:  Sci Rep       Date:  2022-05-05       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.